Diaceutics PLC Investor Relations
Investor Overview
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharma companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.
DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs.
Diaceutics' data capability is one of the three key value drivers it has integrated into its unique DXRX platform alongside its global lab network and product suite tailored for precision testing.
Corporate Overview Presentation - Sept-Oct 2025
H1 2025 Interim Results Presentation
Diaceutics’ CEO Ryan Keeling and CFO Nick Roberts provided an update on the Company's H1 2025 results on September 23rd.
Upcoming Events
2025
HY Results 2025
15th SepUpcoming Events
2025
HY Results 2025
15th SepFeatured Investor News
Investor Alerts
If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.